Drug Trial Radar · NCT04989699
Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration
Last checked: Nov 20, 2026Latest source record: Jan 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
Jul 28, 2021
Primary completion
Feb 6, 2023
Study completion Dec 18, 2023
Sponsor
- Lead sponsor
- Ocular Therapeutix, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 4, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the safety, tolerability, and efficacy of OTX-TKI for intravitreal use in subjects with Neovascular Age-Related Macular Degeneration
Conditions
- Neovascular Age-Related Macular Degeneration
Interventions
OTX-TKI/ShamDrug
OTX-TKI is one dose so subsequent visits will be sham to maintain the mask
Aflibercept/ShamDrug
Aflibercept administered every 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and TolerabilityTime frame: Through study completion, an average of 1 year
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Ocular Therapeutix
Bakersfield, California
Ocular Therapeutix
Oxnard, California
Ocular Therapeutix
Altamonte Springs, Florida
Ocular Therapeutix
St. Petersburg, Florida
Ocular Therapeutix
Reno, Nevada
Ocular Therapeutix
The Woodlands, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.